A Sinovac |
B BioNTech |
C AstraZeneca |
D Not sure |
|
(1) Which of the following vaccines use “genetically modified messenger RNA (mRNA)” as a technology platform? | ||||
(2) Which of the following vaccine uses a technical platform that previously known for hepatitis A vaccine? | ||||
(3) Which of the following vaccines needs to be stored at extremely low temperature (−70 °C) to maintain effectiveness? | ||||
(4) Which of the following vaccines has serious side effects including transverse myelitis? | ||||
(5) Which of the following vaccines has a clinical protective effectiveness of 95%? |